PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment

Duke-NUS scientists have built one of the largest and most comprehensive maps of the developing human brain, marking a major step forward in testing new therapies for Parkinson’s disease and other neurological conditions

2025-11-03
(Press-News.org) SINGAPORE, 03 NOVEMBER 2025—Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps of the developing human brain. The atlas captures nearly every cell type, their genetic fingerprints, and how they grow and interact. It also benchmarks best-in-class laboratory methods for producing high-quality neurons, marking a major step towards new therapies for Parkinson’s disease and other brain disorders.

Parkinson’s disease is Singapore’s second most common neurodegenerative disorder, affecting about three in every 1,000 people aged 50 and above[1]. The condition damages midbrain dopaminergic neurons—cells that release the chemical dopamine to control movement and learning. Restoring these cells could one day help alleviate symptoms such as tremors and mobility loss.

To better understand how these neurons develop when grown in a laboratory, the Duke-NUS team built a two-step mapping framework called BrainSTEM (Brain Single-cell Two tiEr Mapping). Working with partners, including the University of Sydney, they analysed nearly 680,000 cells from the fetal brain to map the entire cellular landscape.

The second higher-resolution projection focuses on the midbrain—pinpointing dopaminergic neurons with greater precision. This “comprehensive reference map” now provides scientists worldwide with a standard to evaluate the accuracy of midbrain models, compared to the real human brain.

Dr Hilary Toh, an MD-PhD candidate from the Neuroscience & Behavioural Disorders programme at Duke-NUS Medical School and one of the first authors of the paper, said:

“Our data-driven blueprint helps scientists produce high-yield midbrain dopaminergic neurons that faithfully reflect human biology. Grafts of this quality are pivotal to increasing cell therapy efficacy and minimising side effects, paving the way to offer alternative therapies to people living with Parkinson’s disease.”

The study, which was recently published in the journal Science Advances, found that many methods used to grow midbrain cells also produced unwanted cells from other brain regions. This shows that both the lab techniques and the data analysis need improvement to detect and remove these off-target cells.

Dr John Ouyang, Principal Research Scientist from Duke-NUS’ Centre for Computational Biology and a senior author of the study, said:

“By mapping the brain at single-cell resolution, BrainSTEM gives us the precision to distinguish even subtle off-target cell populations. This rich cellular detail provides a critical foundation for AI-driven models that will transform how we group patients and design targeted therapies for neurodegenerative diseases.”

Assistant Professor Alfred Sun from Duke-NUS’ Neuroscience & Behavioural Disorders programme, who’s also a senior author of the paper, added:

“BrainSTEM marks a significant step forward in brain modelling. By delivering a rigorous, data-driven approach, it will speed the development of reliable cell therapies for Parkinson’s disease. We’re setting a new standard to ensure the next generation of Parkinson’s models truly reflects human biology.”

The team will provide their brain atlases as an open-source reference and the multi-tier mapping process as a ready-to-use package. With BrainSTEM being a framework that can be applied to sieve out any cell type in the brain, labs worldwide can deploy it to deepen insights, refine workflows and accelerate discovery across neuroscience.

Professor Patrick Tan, Senior Vice-Dean for Research at Duke-NUS, said:

“This study redefines the benchmark—establishing multi-tier mapping as essential for capturing cellular detail in complex biological systems. By revealing how the human midbrain develops in such detail, we will accelerate Parkinson’s research and cell therapy, delivering better care and offer hope to people living with the disease.”

This research was supported by programmes including the USyd-NUS Ignition Grant and the Duke-NUS Parkinson’s Research Fund through the generous donation by The Ida C. Morris Falk Foundation.

Duke-NUS is a leader in medical research and education, with a commitment to improving patient care through innovative scientific discovery. This study is part of its ongoing efforts to deepen understanding of the fundamental mechanisms at play in the human brain to create new therapeutic approaches, especially for patients with neurological conditions.

[1] Tan, L.C.S., Venketasubramanian, N., Jamora, R.D.G. and Heng, D., 2007. Incidence of Parkinson's disease in Singapore. Parkinsonism & Related Disorders, 13(1), pp.40-43.

 

About Duke-NUS Medical School                 

Duke-NUS is Singapore’s flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.   

For more information, please visit www.duke-nus.edu.sg 

END



ELSE PRESS RELEASES FROM THIS DATE:

USF study finds smarter way to train employees to thwart phishing scams

2025-11-03
Media Contact: John Dudley (814) 490-3290 (cell) jjdudley@usf.edu Click here for images and a PDF of the journal article Key takeaways Phishing “gotcha” tests may backfire: New USF-led research finds that on-the-spot phishing training can trigger defensiveness and limit learning — making employees less likely to absorb lessons that prevent future attacks. Broader feedback builds stronger defenses: Training everyone after a phishing simulation — not just those who clicked — helped participants stay alert and resist scams for months. Rethinking a cybersecurity ‘best practice’: The study challenges ...

Antimicrobial peptides can reduce salmonella in chickens

2025-11-03
Key Points: Antimicrobial resistance is a growing global threat to public health, and finding alternatives to antibiotics can help combat increasing antimicrobial resistance (AMR). A new study found that antimicrobial peptides can combat Salmonella infections in chickens, a major cause of foodborne disease in the U.S. This discovery could help improve food safety and protect public health without relying on antibiotic use. Washington, D.C.—Antimicrobial peptides can control Salmonella infections in chickens and thus have the potential to improve food safety and public health, according to a new study. The study was published in Microbiology Spectrum, a journal of the American Society ...

Short fasts do not impair thinking ability in healthy adults

2025-11-03
Skipping breakfast or practicing intermittent fasting is unlikely to cloud most adults’ thinking in the short term, according to research published by the American Psychological Association. Fasting, which can involve abstaining from food for several hours to days, has become one of the more popular contemporary eating regimens, often promoted for potential health benefits such as improved insulin sensitivity, cellular repair and weight management. “While fasting has become trendy over the years, there is widespread concern, often reflected in common sayings like, ‘You’re not ...

Bill Gropp named chair of CRA’s Computing Community Consortium

2025-11-03
National Center for Supercomputing Applications Director Bill Gropp was selected as the next chair of the Computing Research Association’s Computing Community Consortium (CCC). Gropp will formally begin his term following approval from the U.S. National Science Foundation, serving in the role through June 30, 2028. Gropp joined the CCC in 2020 and has been a member of its executive committee since 2021, helping guide the group’s strategy through a challenging environment for computing research while remaining committed to the values he’s displayed ...

Novel S-Scheme photocatalyst efficiently purifies antibiotic-contaminated water

2025-11-03
A breakthrough study published in Chinese Journal of Catalysis presents a powerful new tool in the fight against water pollution: an S-scheme heterojunction photocatalyst that efficiently degrades antibiotic contaminants. This innovative material, composed of Mn0.5Cd0.5S/In2S3 (MCS/IS), not only cleans water effectively but also significantly reduces the toxicity of the breakdown products, addressing a critical challenge in environmental remediation. The widespread use and improper disposal of antibiotics like tetracycline hydrochloride (TCH) have led to their accumulation in water sources, posing severe threats to ecosystem health and contributing to the rise of antibiotic-resistant ...

Plugging nanoscopic cracks to make hydrogen cleaner and cheaper

2025-11-03
Hydrogen is already an important source of energy. The $250 billion industry supports fertilizer production, steel manufacturing, oil refining, and dozens of other vital activities. While nearly all hydrogen produced today is created using carbon-intensive methods, researchers are racing to develop cheaper ways of producing hydrogen with a lower carbon footprint. One of the most promising approaches is water electrolysis, a process that uses electricity to power a reactor — called an electrolyzer — to split water (H2O) molecules into hydrogen (H2) and oxygen (O2).  Electrolyzers ...

Study: More states eliminating insurance hurdles for opioid use disorder medications

2025-11-03
A new study from Tulane University found that, over the past decade, more states have moved to make it easier for people with opioid use disorder to get potentially life-saving medication. The study published in Health Affairs found that, as of 2023, 22 states have passed laws prohibiting private insurance plans from requiring prior authorization, a process that requires doctors to get insurer approval before prescribing certain medications for opioid use disorder. That’s an increase from only two states in 2015. “This signals a positive trend that states ...

Women missing cardiac rehabilitation, despite key benefits

2025-11-03
For someone who has heart surgery or experiences a major cardiovascular event, cardiac rehabilitation can significantly improve their short and long term recovery. People who participate in this comprehensive exercise, lifestyle and education program are less likely to be readmitted to the hospital and have a lower risk of future heart attack. Despite a slew of benefits linked to cardiac rehabilitation, attendance remains poor — with even fewer women utilizing the program. “Even when women do participate, the research tells us that ...

Exposure to more artificial light at night may raise heart disease risk

2025-11-03
Research Highlights Higher levels of exposure to artificial light at night were linked to increased stress-related activity in the brain, inflamed arteries and a higher risk of heart disease, according to a small study of adults in Boston. Nighttime light pollution appeared to affect heart health, making it an environmental factor that could be changed to help reduce heart disease in communities with higher levels of nighttime light, researchers said. Note: The study featured in this news release is a research abstract. Abstracts presented ...

Optimal cardiovascular health among people with Type 2 diabetes may offset dementia risk

2025-11-03
Research Highlights: Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 metrics, may decrease the risk of mild cognitive impairment and dementia for adults with Type 2 diabetes. Among adults with both Type 2 diabetes and a high genetic risk for dementia, researchers found that having moderate or high cardiovascular health, compared to having low cardiovascular health, greatly lowered the risk of developing mild cognitive impairment and dementia over 13 years. Note: The study featured in this news release is a research abstract. Abstracts presented at American Heart Association’s ...

LAST 30 PRESS RELEASES:

Eric Nestler receives the UNIGE Synapsy Prize 2025

Artificial intelligence, wellness apps alone cannot solve mental health crisis

Fair fare

Two Keck Medicine of USC hospitals earn ‘A’ Leapfrog hospital safety grade

Systematic review of multimodal physiological signals from wearable sensors for affective computing

Newly discovered predatory “warrior” was a precursor of the crocodile – and although it lived before the early dinosaurs, it looked just like one

Ultrathin gallium nitride quantum‑disk‑in‑nanowire‑enabled reconfigurable bioinspired sensor for high‑accuracy human action recognition

First high-precision measurement of potential dynamics inside reactor-grade fusion plasma

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy

Common gout drug may reduce risk of heart attack and stroke

Headache disorders affect 3 billion people worldwide—nearly one in every three people, ranking sixth for health loss in 2023

Mayo Clinic scientists create tool to predict Alzheimer's risk years before symptoms begin

Extending anti-clotting treatment linked to lower rates of new clots

E-cigarettes compromise children’s human rights

The Lancet Child & Adolescent Health: High blood pressure in children and adolescents nearly doubled between 2000 and 2020, suggests largest global study to date

EuTYPH-C Inj.® Multi-dose demonstrates strong safety and immunogenicity: Results now available from a Phase 3 study

Fossil fuel CO2 emissions hit record high in 2025

Bold action needed to fix NHS clinical placement crisis

Six strategies to reinvigorate the doctor-patient bedside encounter

Mount Sinai study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

How climate change brings wildlife to the yard

Plants balance adaptability in skin cells with stability in sex cells

UH Wolff Center for Entrepreneurship ranked No. 1 for seventh consecutive year

New study reveals long-term impacts on Stevens-Johnson syndrome survivors

New study reveals how your income may shape your risk of dementia

Texas A&M researchers use AI to identify genetic ‘time capsule’ that distinguishes species

Rainfall and temperature shape mosquito fauna in Atlantic Forest bromeliads, including malaria vectors

Scientists move closer to better pancreatic cancer treatments

Three Tufts professors are named top researchers in the world

New angio-CT technology integrates cutting-edge imaging to enhance patient care

[Press-News.org] Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment
Duke-NUS scientists have built one of the largest and most comprehensive maps of the developing human brain, marking a major step forward in testing new therapies for Parkinson’s disease and other neurological conditions